NCT03096665 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Blumenfeld TA, Hertelendy WG, Ford SH
Simultaneously obtained skin-puncture serum, skin-puncture plasma, and venous serum compared, and effects of warming the skin before puncture. Clin Chem. 1977 Sep;23(9):1705-10.
Falch DK
Clinical chemical analyses of serum obtained from capillary versus venous blood, using Microtainers and Vacutainers. Scand J Clin Lab Invest. 1981 Feb;41(1):59-62.
Kupke IR, Kather B, Zeugner S
On the composition of capillary and venous blood serum. Clin Chim Acta. 1981 May 5;112(2):177-85.
Sobiech P, Pomianowski A, Stopyra A, Kuleta Z, Zbanyszek M, Procajlo A, Rajski K
Acid-base balance parameters and ionic composition of arterial, venous and capillary blood in goats. Pol J Vet Sci. 2004;7(2):117-21.

Correlation Between the Point of Care Blood Analysis Obtained From Skin Puncture Blood and Conventional Blood Analysis Obtained From Venous and Arterial Blood

Details for clinical trial NCT03096665

Clinical trial NCT03096665 - References